[TNGX] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
08-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -7.50%
YoY- 20.99%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 11,607 10,732 6,920 6,787 -11,261 -
PBT -29,113 -22,240 -29,050 -19,528 -26,802 2.08%
Tax -54 23 -873 62 50 -
NP -29,167 -22,263 -28,177 -19,590 -26,802 2.13%
Tax Rate - - - - - -
Total Cost 40,774 32,995 35,097 26,377 15,541 27.24%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin -251.29 -207.45 -407.18 -288.64 238.01 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -0.27 -0.23 -0.32 -0.28 -0.31 -3.39%
EPS Diluted -0.27 -0.23 -0.32 -0.28 -0.31 -3.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.